Treatment of MOC1 tumor-bearing mice with CTLA-4 mAb plus gMDSC depletion in the presence of cellular depleting mAbs revealed that tumor rejection is dependent upon CD8+ but not CD4+ or NK cells (Figure 9F). The gene discussed is CTLA4; the disease is neoplasm.